Pharmacologic modification of radiation-induced late normal tissue injury.
Moulder
J E
JE
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee 53226, USA.
Robbins
M E
ME
Cohen
E P
EP
Hopewell
J W
JW
Ward
W F
WF
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D002216:Captopril / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000528:radiation effects; D011832:Radiation Injuries / Q000188:drug therapy / Q000517:prevention & control*; D011833:Radiation Injuries, Experimental / Q000188:drug therapy / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects / Q000528:radiation effects
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril